Gerresheimer AG logo

Gerresheimer AG (1GXI)

Market Closed
9 Jun, 15:30
XMIL XMIL
26. 08
0
0%
- Market Cap
29.23 P/E Ratio
5% Div Yield
260 Volume
5.32 Eps
26.08
Previous Close
Add Transaction
Day Range
26.08 26.08
Year Range
15.8 48.82
Want to track 1GXI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

1GXI closed Tuesday higher at €26.08, an increase of 0% from Monday's close, completing a monthly increase of 9.5798% or €2.28. Over the past 12 months, 1GXI stock lost -5.3701%.
1GXI pays dividends to its shareholders, with the most recent payment made on Jun 09, 2026. The next estimated payment will be in 4 days ago on Jun 09, 2026 for a total of €0.04.
The last earnings report, released on Apr 16, 2026, missed the consensus estimates by -0.41%. On average, the company has fell short of earnings expectations by -0.1167%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 12 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

1GXI Chart

Gerresheimer AG (1GXI) FAQ

What is the stock price today?

The current price is €26.08.

On which exchange is it traded?

Gerresheimer AG is listed on XMIL.

What is its stock symbol?

The ticker symbol is 1GXI.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 5%.

What is its market cap?

As of today, no market cap data is available.

Has Gerresheimer AG ever had a stock split?

No, there has never been a stock split.

Gerresheimer AG Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Uwe Ferdinand Röehrhoff CEO
XMIL Exchange
DE000A0LD6E6 ISIN
DE Country
13,632 Employees
5 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

Gerresheimer AG is an established leader in the production and distribution of specialized packaging solutions and drug delivery systems for the pharmaceutical, biotechnology, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. With a rich history dating back to 1864, the company has grown to serve clients globally, with its headquarters situated in Düsseldorf, Germany. It operates through three main divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies, demonstrating a broad and innovative product portfolio designed to meet the complex needs of its clients in Germany and across the world.

Products and Services

  • Prefillable Syringes & Packaging Solutions: Gerresheimer AG offers a wide range of prefillable syringes, alongside plastic and glass packaging solutions such as vials, glass cartridges, and ampoules. These crucial components are designed for the safe and effective delivery of medications.
  • Bottles & Containers: The company produces both glass and plastic bottles and containers for various applications, along with specialized products like capsules, closures, applicators, and accessories to suit the diverse needs of the industries it serves.
  • Drug Delivery Programs: Gerresheimer offers comprehensive services in the development, industrialization, and contract manufacturing of drug delivery programs. Supported by project and quality management services, these solutions cater to inhalers, injection/autoinjectors, pen injectors, and infusion systems, emphasizing the significance of reliable drug delivery mechanisms.
  • Diagnostic & Medical Devices: The company manufactures diagnostic and medical devices, including point-of-care tests and laboratory disposables. It also offers chemical and technical bottles, diagnostic polymer vials, dropper bottles, PET bottles, and a variety of medical products such as lancing devices and infusion sets.
  • Cosmetic Packaging Solutions: Gerresheimer extends its expertise to the cosmetics industry by providing attractive and functional packaging solutions, including molded glass flacons and jars, tubular glass ampoules, droppers, samplers, vials, and a range of plastic packaging products.
  • Pharmaceutical, Laboratory, & Regulatory Affairs Services: The company is not only a manufacturer but also a service provider, offering a spectrum of pharmaceutical, laboratory, and regulatory affairs services to ensure compliance and facilitate the successful launch of products in various markets.

Contact Information

Address: Klaus-Bungert-Strasse 4
Phone: 49 211 61 81 00